FDA approves St. Jude Medical’s cardiac mapping system
The FDA cleared the EnSite Precision cardiac mapping system and the Advisor FL circular mapping catheter for patients with cardiac arrhythmias.
St. Jude Medical, which manufactures the mapping system and catheter, announced the approvals in a news release on Dec. 15.
The company said that that EnSite Precision cardiac mapping system provides physicians with a live view of the heart, anatomical models and maps to help them treat atrial fibrillation, ventricular tachycardia and other arrhythmias.
The EnSite Precision is based on St. Jude Medical’s Ensite Velocity cardiac mapping system, which the company said is in use in more than 2,000 electrophysiology laboratories. The EnSite Precision features a module that the company said would allow physicians to build a map of the heart 10 times faster than current systems.
The EnSite Precision received a CE Mark in Europe in January.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.